Peter Howard Weinstock, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Simulation | 6 | 2017 | 297 | 1.550 |
Why?
|
| Cleft Lip | 4 | 2023 | 506 | 1.280 |
Why?
|
| Models, Anatomic | 6 | 2024 | 683 | 1.210 |
Why?
|
| Manikins | 8 | 2023 | 244 | 0.980 |
Why?
|
| Clinical Competence | 14 | 2023 | 4788 | 0.960 |
Why?
|
| Diazepam | 1 | 2023 | 215 | 0.800 |
Why?
|
| Vein of Galen Malformations | 1 | 2023 | 58 | 0.790 |
Why?
|
| Video Games | 1 | 2023 | 197 | 0.710 |
Why?
|
| Curriculum | 11 | 2023 | 3741 | 0.670 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2019 | 39 | 0.650 |
Why?
|
| Play and Playthings | 1 | 2019 | 85 | 0.630 |
Why?
|
| Masks | 1 | 2020 | 209 | 0.600 |
Why?
|
| Child, Hospitalized | 1 | 2019 | 182 | 0.580 |
Why?
|
| Inservice Training | 5 | 2014 | 375 | 0.580 |
Why?
|
| Internship and Residency | 6 | 2023 | 5885 | 0.570 |
Why?
|
| Vascular Malformations | 1 | 2023 | 468 | 0.560 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 2018 | 118 | 0.550 |
Why?
|
| Craniofacial Dysostosis | 1 | 2016 | 74 | 0.530 |
Why?
|
| Home Care Services | 2 | 2020 | 647 | 0.510 |
Why?
|
| Caregivers | 4 | 2021 | 2244 | 0.480 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1160 | 0.460 |
Why?
|
| Anxiety | 5 | 2021 | 4569 | 0.460 |
Why?
|
| Organizational Innovation | 1 | 2017 | 538 | 0.460 |
Why?
|
| Computer Simulation | 8 | 2022 | 6224 | 0.450 |
Why?
|
| Osteogenesis, Distraction | 1 | 2016 | 230 | 0.450 |
Why?
|
| Lipoprotein Lipase | 7 | 1999 | 133 | 0.440 |
Why?
|
| Nurses | 1 | 2023 | 2477 | 0.430 |
Why?
|
| Anticonvulsants | 1 | 2023 | 1910 | 0.420 |
Why?
|
| Robotics | 1 | 2019 | 817 | 0.400 |
Why?
|
| Education, Medical | 4 | 2018 | 1725 | 0.400 |
Why?
|
| Patient Care Team | 4 | 2014 | 2515 | 0.390 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 1069 | 0.390 |
Why?
|
| Pediatrics | 4 | 2015 | 3590 | 0.390 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2010 | 991 | 0.380 |
Why?
|
| Teaching | 2 | 2010 | 1171 | 0.360 |
Why?
|
| Hydrocephalus | 1 | 2017 | 764 | 0.350 |
Why?
|
| Wounds and Injuries | 1 | 2023 | 2493 | 0.350 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2023 | 1017 | 0.340 |
Why?
|
| Neurosurgical Procedures | 2 | 2017 | 2067 | 0.320 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 1427 | 0.320 |
Why?
|
| Cardiology Service, Hospital | 1 | 2010 | 240 | 0.300 |
Why?
|
| Catheterization | 1 | 2013 | 1428 | 0.300 |
Why?
|
| Pain | 2 | 2020 | 5072 | 0.290 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 5333 | 0.280 |
Why?
|
| Critical Care | 2 | 2012 | 2696 | 0.270 |
Why?
|
| Airway Obstruction | 1 | 2011 | 660 | 0.260 |
Why?
|
| Critical Illness | 1 | 2019 | 2724 | 0.260 |
Why?
|
| Emergencies | 2 | 2011 | 1217 | 0.250 |
Why?
|
| Intensive Care Units | 1 | 2019 | 3744 | 0.250 |
Why?
|
| Health Resources | 1 | 2011 | 934 | 0.240 |
Why?
|
| Education, Continuing | 1 | 2005 | 114 | 0.240 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 825 | 0.240 |
Why?
|
| Child | 15 | 2024 | 80154 | 0.230 |
Why?
|
| Otolaryngology | 1 | 2011 | 693 | 0.220 |
Why?
|
| Gastroenterology | 1 | 2010 | 580 | 0.220 |
Why?
|
| Health Personnel | 1 | 2017 | 3337 | 0.220 |
Why?
|
| Administration, Rectal | 1 | 2023 | 69 | 0.220 |
Why?
|
| Personnel, Hospital | 1 | 2005 | 285 | 0.220 |
Why?
|
| Surgery, Plastic | 2 | 2022 | 640 | 0.220 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1405 | 0.210 |
Why?
|
| Radiology | 1 | 2016 | 2112 | 0.210 |
Why?
|
| Boston | 5 | 2018 | 9327 | 0.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 1462 | 0.200 |
Why?
|
| Ethics Committees, Research | 1 | 2023 | 196 | 0.190 |
Why?
|
| Humans | 46 | 2024 | 761222 | 0.180 |
Why?
|
| Point-of-Care Systems | 1 | 2009 | 1212 | 0.170 |
Why?
|
| Cochlear Implantation | 1 | 2024 | 316 | 0.170 |
Why?
|
| Neurosurgery | 2 | 2017 | 679 | 0.170 |
Why?
|
| Attitude of Health Personnel | 2 | 2011 | 3885 | 0.170 |
Why?
|
| Temporal Bone | 1 | 2024 | 683 | 0.170 |
Why?
|
| Pleasure | 1 | 2019 | 41 | 0.160 |
Why?
|
| Urodynamics | 1 | 2020 | 346 | 0.150 |
Why?
|
| Health Facilities | 1 | 2023 | 575 | 0.150 |
Why?
|
| Housing | 1 | 2023 | 669 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2008 | 1513 | 0.150 |
Why?
|
| Problem-Based Learning | 1 | 2021 | 356 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 3627 | 0.150 |
Why?
|
| Urethra | 1 | 2020 | 405 | 0.150 |
Why?
|
| Triglycerides | 6 | 1999 | 2457 | 0.150 |
Why?
|
| Status Epilepticus | 1 | 2023 | 461 | 0.140 |
Why?
|
| Computers, Handheld | 1 | 2019 | 210 | 0.140 |
Why?
|
| Apolipoproteins A | 1 | 1997 | 95 | 0.140 |
Why?
|
| Analgesia | 1 | 2021 | 461 | 0.140 |
Why?
|
| Cholesterol, HDL | 3 | 1999 | 1812 | 0.140 |
Why?
|
| Feedback, Psychological | 1 | 2017 | 96 | 0.140 |
Why?
|
| Family Relations | 1 | 2019 | 317 | 0.140 |
Why?
|
| Stress, Psychological | 2 | 2020 | 4487 | 0.140 |
Why?
|
| Pilot Projects | 4 | 2021 | 8642 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2020 | 426 | 0.130 |
Why?
|
| Patient Discharge | 2 | 2019 | 3441 | 0.130 |
Why?
|
| Hypertriglyceridemia | 2 | 1996 | 292 | 0.130 |
Why?
|
| Osteotomy, Le Fort | 1 | 2016 | 93 | 0.130 |
Why?
|
| Meningomyelocele | 1 | 2017 | 172 | 0.130 |
Why?
|
| Video Recording | 2 | 2011 | 965 | 0.120 |
Why?
|
| Lipoproteins, HDL | 2 | 1997 | 675 | 0.120 |
Why?
|
| Triage | 1 | 2021 | 985 | 0.120 |
Why?
|
| Kyphosis | 1 | 2017 | 251 | 0.120 |
Why?
|
| Abscess | 1 | 2018 | 605 | 0.110 |
Why?
|
| Casts, Surgical | 1 | 2015 | 184 | 0.110 |
Why?
|
| Spinal Fusion | 2 | 2021 | 1294 | 0.110 |
Why?
|
| Aftercare | 1 | 2019 | 913 | 0.110 |
Why?
|
| Child, Preschool | 5 | 2024 | 42225 | 0.110 |
Why?
|
| Hospitals, Teaching | 2 | 2009 | 1155 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 637 | 0.100 |
Why?
|
| Drainage | 1 | 2018 | 1157 | 0.100 |
Why?
|
| Insurance Carriers | 1 | 2014 | 155 | 0.100 |
Why?
|
| Adult | 11 | 2024 | 221120 | 0.100 |
Why?
|
| Program Development | 2 | 2010 | 1294 | 0.100 |
Why?
|
| Movement | 1 | 2018 | 1476 | 0.100 |
Why?
|
| Adipose Tissue | 3 | 1999 | 3313 | 0.090 |
Why?
|
| Restriction Mapping | 2 | 1991 | 849 | 0.090 |
Why?
|
| Brain | 2 | 2016 | 27094 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5250 | 0.090 |
Why?
|
| Seizures | 1 | 2023 | 2965 | 0.090 |
Why?
|
| Scoliosis | 1 | 2017 | 790 | 0.090 |
Why?
|
| Singapore | 1 | 2010 | 292 | 0.080 |
Why?
|
| Fatty Acids | 1 | 1997 | 1807 | 0.080 |
Why?
|
| Family | 1 | 2020 | 3192 | 0.080 |
Why?
|
| Female | 15 | 2024 | 392552 | 0.080 |
Why?
|
| Equipment Design | 1 | 2017 | 3510 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 1997 | 1893 | 0.080 |
Why?
|
| Group Processes | 1 | 2010 | 228 | 0.080 |
Why?
|
| Educational Measurement | 2 | 2018 | 1250 | 0.080 |
Why?
|
| Tachycardia | 1 | 2010 | 599 | 0.080 |
Why?
|
| Lipoproteins, VLDL | 3 | 1998 | 201 | 0.070 |
Why?
|
| Airway Management | 1 | 2011 | 312 | 0.070 |
Why?
|
| Operating Rooms | 1 | 2014 | 790 | 0.070 |
Why?
|
| Nursing Staff, Hospital | 1 | 2011 | 348 | 0.070 |
Why?
|
| Apolipoproteins C | 2 | 1997 | 59 | 0.070 |
Why?
|
| Pregnancy | 3 | 2023 | 29893 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 8002 | 0.070 |
Why?
|
| Orthopedics | 1 | 2015 | 898 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 2374 | 0.070 |
Why?
|
| Cost Control | 1 | 2009 | 627 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2010 | 763 | 0.070 |
Why?
|
| Vitamin A | 3 | 1999 | 612 | 0.060 |
Why?
|
| Intestinal Absorption | 2 | 1997 | 400 | 0.060 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 931 | 0.060 |
Why?
|
| Adolescent | 7 | 2024 | 88300 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2854 | 0.060 |
Why?
|
| Male | 14 | 2024 | 360703 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2011 | 876 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2010 | 2359 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1506 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9319 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2023 | 54437 | 0.060 |
Why?
|
| Infant | 3 | 2021 | 36170 | 0.060 |
Why?
|
| Staff Development | 1 | 2005 | 227 | 0.060 |
Why?
|
| DNA | 3 | 1995 | 7189 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5493 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 1998 | 1168 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2016 | 5969 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 36415 | 0.050 |
Why?
|
| Facility Design and Construction | 1 | 2023 | 85 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2010 | 2489 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 2004 | 0.050 |
Why?
|
| Malawi | 1 | 2021 | 300 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2018 | 80675 | 0.040 |
Why?
|
| Time Factors | 3 | 2013 | 39957 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2009 | 1862 | 0.040 |
Why?
|
| Chylomicrons | 1 | 1999 | 26 | 0.040 |
Why?
|
| Nose | 1 | 2022 | 521 | 0.040 |
Why?
|
| Apolipoprotein C-III | 2 | 1997 | 210 | 0.040 |
Why?
|
| Heart Rate | 1 | 2010 | 4197 | 0.040 |
Why?
|
| Lipoproteins | 3 | 1999 | 877 | 0.040 |
Why?
|
| Emotions | 1 | 2010 | 2742 | 0.040 |
Why?
|
| Mice, Transgenic | 7 | 1999 | 9520 | 0.040 |
Why?
|
| Genetic Techniques | 2 | 1991 | 428 | 0.040 |
Why?
|
| Cholesterol Esters | 1 | 1997 | 72 | 0.040 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 1998 | 65 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 2021 | 533 | 0.040 |
Why?
|
| Printing | 1 | 2017 | 46 | 0.040 |
Why?
|
| Globins | 1 | 1998 | 405 | 0.030 |
Why?
|
| Mice, Obese | 1 | 1997 | 418 | 0.030 |
Why?
|
| Patient Care | 1 | 2021 | 623 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 1997 | 299 | 0.030 |
Why?
|
| Heme | 1 | 1998 | 313 | 0.030 |
Why?
|
| Microbodies | 1 | 1995 | 36 | 0.030 |
Why?
|
| Growth | 1 | 1997 | 366 | 0.030 |
Why?
|
| Dietary Fats | 3 | 1999 | 1994 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 4014 | 0.030 |
Why?
|
| Mitochondrial Myopathies | 1 | 1995 | 50 | 0.030 |
Why?
|
| Muscles | 2 | 1997 | 1568 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1995 | 775 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2024 | 2241 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 297 | 0.030 |
Why?
|
| Electromyography | 1 | 2020 | 1393 | 0.030 |
Why?
|
| Nurse Practitioners | 1 | 2018 | 269 | 0.030 |
Why?
|
| Mice, Knockout | 4 | 1999 | 14392 | 0.030 |
Why?
|
| United States | 1 | 2023 | 72341 | 0.030 |
Why?
|
| Focus Groups | 1 | 2020 | 1413 | 0.030 |
Why?
|
| Mitochondria, Muscle | 1 | 1995 | 172 | 0.030 |
Why?
|
| Middle Aged | 4 | 2024 | 220858 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 1998 | 2665 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15637 | 0.030 |
Why?
|
| Stem Cells | 2 | 1998 | 3517 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1995 | 392 | 0.030 |
Why?
|
| Receptors, Fc | 1 | 1997 | 537 | 0.030 |
Why?
|
| Quality Improvement | 2 | 2021 | 3808 | 0.030 |
Why?
|
| Young Adult | 3 | 2020 | 59222 | 0.030 |
Why?
|
| Mice | 11 | 1999 | 81330 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2017 | 64681 | 0.030 |
Why?
|
| Cognition | 1 | 2010 | 6988 | 0.030 |
Why?
|
| Biological Transport | 1 | 1997 | 2081 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1991 | 1301 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2020 | 2697 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 1995 | 643 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 1999 | 4947 | 0.030 |
Why?
|
| Personnel Selection | 1 | 2014 | 196 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1998 | 1668 | 0.020 |
Why?
|
| Lipids | 3 | 1997 | 3331 | 0.020 |
Why?
|
| Osteotomy | 1 | 2017 | 836 | 0.020 |
Why?
|
| RNA, Messenger | 5 | 1998 | 12747 | 0.020 |
Why?
|
| Phagocytosis | 1 | 1997 | 1525 | 0.020 |
Why?
|
| Liver | 2 | 1998 | 7512 | 0.020 |
Why?
|
| Death | 1 | 1995 | 677 | 0.020 |
Why?
|
| Eating | 1 | 1997 | 1535 | 0.020 |
Why?
|
| Cholesterol | 2 | 1998 | 2902 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1995 | 1149 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2020 | 3024 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 1991 | 353 | 0.020 |
Why?
|
| Mathematics | 1 | 1990 | 702 | 0.020 |
Why?
|
| Heterozygote | 1 | 1995 | 2778 | 0.020 |
Why?
|
| Animals | 12 | 1999 | 168089 | 0.020 |
Why?
|
| Mentors | 1 | 2014 | 663 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1998 | 2413 | 0.020 |
Why?
|
| Glucose | 2 | 1997 | 4342 | 0.020 |
Why?
|
| Dendrites | 1 | 1991 | 471 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 26200 | 0.020 |
Why?
|
| Gene Expression | 2 | 1998 | 7571 | 0.020 |
Why?
|
| Genotype | 3 | 1998 | 12985 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 20588 | 0.020 |
Why?
|
| Weight Gain | 1 | 1997 | 2349 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3200 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 3726 | 0.020 |
Why?
|
| Organ Specificity | 3 | 1999 | 1963 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2015 | 1545 | 0.020 |
Why?
|
| Body Composition | 1 | 1995 | 2427 | 0.020 |
Why?
|
| Radiography | 1 | 2017 | 6974 | 0.020 |
Why?
|
| Myocardium | 1 | 1999 | 4746 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 1997 | 3183 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20118 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 1999 | 11855 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 4052 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 74241 | 0.010 |
Why?
|
| Base Sequence | 2 | 1991 | 12404 | 0.010 |
Why?
|
| Kinetics | 1 | 1990 | 6312 | 0.010 |
Why?
|
| Macrophages | 1 | 1997 | 5755 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7865 | 0.010 |
Why?
|
| Fasting | 2 | 1999 | 1603 | 0.010 |
Why?
|
| RNA | 1 | 1991 | 2709 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1991 | 17598 | 0.010 |
Why?
|
| Physicians | 1 | 2018 | 4584 | 0.010 |
Why?
|
| Communication | 1 | 2014 | 3872 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22174 | 0.010 |
Why?
|
| Retinol-Binding Proteins | 1 | 1999 | 67 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8998 | 0.010 |
Why?
|
| Benzidines | 1 | 1998 | 6 | 0.010 |
Why?
|
| Diterpenes | 1 | 1999 | 170 | 0.010 |
Why?
|
| Body Weight | 2 | 1999 | 4618 | 0.010 |
Why?
|
| Ketones | 1 | 1998 | 182 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1998 | 697 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 1751 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1998 | 561 | 0.010 |
Why?
|
| Culture Media | 1 | 1997 | 894 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1995 | 88 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1995 | 452 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1995 | 438 | 0.010 |
Why?
|
| Postprandial Period | 1 | 1996 | 314 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1998 | 838 | 0.010 |
Why?
|
| Lipolysis | 1 | 1995 | 210 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 684 | 0.010 |
Why?
|
| Transgenes | 1 | 1996 | 1008 | 0.010 |
Why?
|
| Neurons | 1 | 1991 | 9429 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 1991 | 152 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 5748 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 1991 | 218 | 0.010 |
Why?
|
| RNA Polymerase III | 1 | 1991 | 57 | 0.010 |
Why?
|
| Heparin | 1 | 1997 | 1632 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 704 | 0.010 |
Why?
|
| Rats | 2 | 1999 | 23705 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1997 | 18927 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3388 | 0.000 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1991 | 484 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8164 | 0.000 |
Why?
|
| Longevity | 1 | 1995 | 1063 | 0.000 |
Why?
|
| Deoxycytidine | 1 | 1991 | 878 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1997 | 2877 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1996 | 4138 | 0.000 |
Why?
|
| Temperature | 1 | 1991 | 2219 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 5773 | 0.000 |
Why?
|
| Weight Loss | 1 | 1995 | 2680 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1991 | 1807 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1991 | 2444 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1991 | 6067 | 0.000 |
Why?
|
| Age Factors | 1 | 1998 | 18384 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1998 | 11512 | 0.000 |
Why?
|
| Diet | 1 | 1998 | 8048 | 0.000 |
Why?
|
| Membrane Glycoproteins | 1 | 1991 | 3696 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 18222 | 0.000 |
Why?
|
| Nerve Tissue Proteins | 1 | 1991 | 4404 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 7571 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1995 | 22128 | 0.000 |
Why?
|
| Mutation | 1 | 1998 | 30004 | 0.000 |
Why?
|